IDO1 and nasopharyngeal carcinoma: We subsequently examined the influence of YK-4-279 on the expression of CBP, STAT1 and IDO1 under IFN-γ treatment, and discerned a reduction in all of these targets in NPC cells (Fig. 5C and Supplementary Fig. S5B–I).